HIV news from aidsmap.com

Water insecurity nearly quadruples odds of poor HIV outcomes, while hunger and partner violence compound risk in East Africa
Adults on HIV treatment in western Kenya who are experiencing water insecurity have nearly four times the odds of poor treatment outcomes, regardless of gender, researchers reported at the 26th International AIDS Conference (AIDS 2026) in Rio de Janeiro. In a separate Ugandan study presented in the same session, delegates heard that women facing intimate partner violence, food insecurity and water insecurity together acquired HIV at eighteen times the rate of women facing none of them.
>> Read more

Monthly PrEP pill could be made for US$3 a year, but Latin America is shut out of generic licensing
Merck's investigational once-monthly PrEP pill could be manufactured and sold profitably for around $3 per person per year, making it the cheapest HIV prevention drug ever brought to market, the 26th International AIDS Conference (AIDS 2026) in Rio de Janeiro heard yesterday. But the licensing deal announced by the company days earlier leaves out most of Latin America, including countries hosting the drug's own phase III trials.
>> Read more

Nearly 200,000 lenacapavir shots given across Africa, but supply issues pose challenges
Lenacapavir – the highly effective HIV prevention medication that only requires two shots a year – is currently rolling out across African countries with a high burden of HIV. Initial data from countries such as Eswatini, Malawi, Mozambique and Kenya were shared at the 26th International AIDS Conference (AIDS 2026) in Rio de Janeiro, Brazil. Demand is already outpacing supply in some instances, with ambitious targets set for 2026 and beyond.
>> Read more